JP2024156672A5 - - Google Patents

Info

Publication number
JP2024156672A5
JP2024156672A5 JP2024108581A JP2024108581A JP2024156672A5 JP 2024156672 A5 JP2024156672 A5 JP 2024156672A5 JP 2024108581 A JP2024108581 A JP 2024108581A JP 2024108581 A JP2024108581 A JP 2024108581A JP 2024156672 A5 JP2024156672 A5 JP 2024156672A5
Authority
JP
Japan
Prior art keywords
methods
substantially described
novel products
manufacturing methods
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024108581A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024156672A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/052927 external-priority patent/WO2019067596A1/en
Application filed filed Critical
Publication of JP2024156672A publication Critical patent/JP2024156672A/ja
Publication of JP2024156672A5 publication Critical patent/JP2024156672A5/ja
Pending legal-status Critical Current

Links

JP2024108581A 2017-09-26 2024-07-05 透過エンハンサーを含む送達医薬組成物 Pending JP2024156672A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762563534P 2017-09-26 2017-09-26
US62/563,534 2017-09-26
PCT/US2018/052927 WO2019067596A1 (en) 2017-09-26 2018-09-26 ADMINISTRATIVE PHARMACEUTICAL COMPOSITIONS CONTAINING PERMEATION PROMOTERS
JP2020538776A JP2020535232A (ja) 2017-09-26 2018-09-26 透過エンハンサーを含む送達医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020538776A Division JP2020535232A (ja) 2017-09-26 2018-09-26 透過エンハンサーを含む送達医薬組成物

Publications (2)

Publication Number Publication Date
JP2024156672A JP2024156672A (ja) 2024-11-06
JP2024156672A5 true JP2024156672A5 (enExample) 2026-04-14

Family

ID=63858155

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020538776A Pending JP2020535232A (ja) 2017-09-26 2018-09-26 透過エンハンサーを含む送達医薬組成物
JP2024108581A Pending JP2024156672A (ja) 2017-09-26 2024-07-05 透過エンハンサーを含む送達医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020538776A Pending JP2020535232A (ja) 2017-09-26 2018-09-26 透過エンハンサーを含む送達医薬組成物

Country Status (9)

Country Link
US (1) US20190091281A1 (enExample)
EP (1) EP3687508A1 (enExample)
JP (2) JP2020535232A (enExample)
KR (1) KR20200059269A (enExample)
CN (1) CN111148512A (enExample)
BR (1) BR112020005875A2 (enExample)
CA (1) CA3076751A1 (enExample)
IL (2) IL311142A (enExample)
WO (1) WO2019067596A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111465391A (zh) * 2017-09-27 2020-07-28 阿奎斯蒂弗医疗股份有限公司 具有增强的递送的肾上腺素和前药的组合物
CA3105187A1 (en) 2018-06-28 2020-01-02 Arx, Llc Dispensing method for producing dissolvable unit dose film constructs
US12440472B2 (en) * 2021-06-16 2025-10-14 Intelgenx Corp. Stable tryptamine oral films

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2193891B (en) * 1986-08-18 1990-07-25 Sandoz Ltd Nasal pharmaceutical composition containing a somatostatin anologue.
GB8620035D0 (en) * 1986-08-18 1986-10-01 Sandoz Ltd Organic compounds
US5879690A (en) * 1995-09-07 1999-03-09 Perricone; Nicholas V. Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
US20030124176A1 (en) * 1999-12-16 2003-07-03 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US7666337B2 (en) 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US7425292B2 (en) 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
SE0302924D0 (sv) * 2003-11-05 2003-11-05 Camurus Ab Pharmaceutical composition having a cationic excipient
US20110257096A1 (en) * 2004-08-25 2011-10-20 Aegis Therapeutics, Inc. Compositions for drug administration
US20060073173A1 (en) * 2004-10-04 2006-04-06 Maria Banach Large-scale manufacturing process for the production of pharmaceutical compositions
KR20130114229A (ko) * 2005-06-03 2013-10-16 애크럭스 디디에스 피티와이 리미티드 경피 약물 전달 방법 및 조성물
CA3044884A1 (en) 2009-12-07 2011-06-16 Arbutus Biopharma Corporation Compositions for nucleic acid delivery
WO2011116139A2 (en) * 2010-03-16 2011-09-22 Chiasma Inc. Improved pharmaceutical compositions and methods of delivery
IE20100174A1 (en) * 2010-03-25 2012-02-29 Trinity College Dublin Transdermal administration of peptides
JP5912126B2 (ja) * 2010-11-26 2016-04-27 ユニバーシティ・オブ・ジ・ウィトウォーターズランド・ヨハネスブルクUniversity Of The Witwatersrand, Johannesburg 医薬投与形態
HK1208812A1 (en) * 2012-07-06 2016-03-18 Leo Pharma A/S A topical composition comprising a film-forming polymer for delivering an active ingredient to skin
FR3013589B1 (fr) * 2013-11-28 2017-03-31 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic Composition d'alkyl polyglucosides et d'acides gras cationisees
WO2017072774A1 (en) * 2015-10-29 2017-05-04 Solubest Ltd Pharmaceutical compositions for transmucosal delivery

Similar Documents

Publication Publication Date Title
JP2026048925A5 (enExample)
JP2023134518A5 (enExample)
JP2024156852A5 (enExample)
JP2024133471A5 (enExample)
JP2026012786A5 (enExample)
JP2022538004A5 (enExample)
JP2023113641A5 (enExample)
JP2025023938A5 (enExample)
JP2023113681A5 (enExample)
JP2023154065A5 (enExample)
JP2024037765A5 (enExample)
JP2023164986A5 (enExample)
JP2025106258A5 (enExample)
JP2023153863A5 (enExample)
JP2025118771A5 (enExample)
JP2024156705A5 (enExample)
JP2025038009A5 (enExample)
JP2023134519A5 (enExample)
JP2024088648A5 (enExample)
JP2023139025A5 (enExample)
JP2023103231A5 (enExample)
JP2025163046A5 (enExample)
JP2025143267A5 (enExample)
JP2025124655A5 (enExample)
JP2025041678A5 (enExample)